跳至主要内容
临床试验/ACTRN12623000537651
ACTRN12623000537651尚未招募Unknown

Accuracy and Feasibility of a Novel Glucose/Lactate/Oxygen/Choline Multi-Analyte Sensing Platform in Humans

St Vincent's Hospital Melbourne0 个研究点目标入组 20 人开始时间: 2023年5月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Participants will be considered for inclusion in the study if they meet all of the following criteria:
  • 1. Participant is 18-65 years of age at time of screening.
  • 2. A clinical diagnosis of Type-1 diabetes, or Type-2 diabetes as determined by the Investigator.
  • 3. Participant is willing to comply with all requirements associated with the protocol.

排除标准

  • Participants will be excluded from the study for any of the following reasons:
  • 1.Participant has experienced an episode of major hypoglycaemia or diabetic ketoacidosis within the last month
  • 2.Participant has a major illness precluding safe implementation of the protocol
  • 3. Participant is or plans to become pregnant during the course of the study.
  • 4. Participant is unable to tolerate tape adhesive in the area of sensor placement.
  • 5. Participant has any unresolved adverse skin condition in the area of sensor or device placement (e.g., psoriasis, rash, Staphylococcus infection).

研究者

发起方
St Vincent's Hospital Melbourne

相似试验

First-in-human Testing of a Multi-Analyte Sensor... | 临床试验